SEARCH

SEARCH BY CITATION

References

  • Annino, L., Vegna, M.L., Camera, A., Specchia, G., Visani, G., Fioritoni, G., Ferrara, F., Peta, A., Ciolli, S., Deplano, W., Fabbiano, F., Sica, S., Di Raimondo, F., Cascavilla, N., Tabilio, A., Leoni, P., Invernizzi, R., Baccarani, M., Rotoli, B., Amadori, S. & Mandelli, F. (2002) Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood, 99, 863871.
  • Assouline-Dayan, Y., Chang, C., Greenspan, A., Shoenfeld, Y. & Gershwin, M.E. (2002) Pathogenesis and natural history of osteonecrosis. Seminars in Arthritis and Rheumatism, 32, 94124.
  • Barry, E., DeAngelo, D.J., Neuberg, D., Stevenson, K., Loh, M.L., Asselin, B.L., Barr, R.D., Clavell, L.A., Hurwitz, C.A., Moghrabi, A., Samson, Y., Schorin, M., Cohen, H.J., Sallan, S.E. & Silverman, L.B. (2007) Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols. Journal of Clinical Oncology, 25, 813819.
  • Bassan, R., Spinelli, O., Oldani, E., Intermesoli, T., Tosi, M., Peruta, B., Rossi, G., Borlenghi, E., Pogliani, E.M., Terruzzi, E., Fabris, P., Cassibba, V., Lambertenghi-Deliliers, G., Cortelezzi, A., Bosi, A., Gianfaldoni, G., Ciceri, F., Bernardi, M., Gallamini, A., Mattei, D., Di Bona, E., Romani, C., Scattolin, A.M., Barbui, T. & Rambaldi, A. (2009) Improved risk classification for risk-specific therapy based on the molecular study of MRD in adult ALL. Blood, doi: DOI: 10.1182/blood-2008-11-185132
  • Beinart, G. & Damon, L. (2004) Thrombosis associated with l-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia. American Journal of Hematology, 77, 331335.
  • French, D., Hamilton, L.H., Mattano, L.A., Sather, H.N., Devidas, M., Nachman, J.B. & Relling, M.V. (2008) A PAI-1 (SERPINEI) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children’s Oncology Group. Blood, 111, 44964499.
  • Goldstone, A.H., Richards, S.M., Lazarus, H.M., Tallman, M.S., Buck, G., Fielding, A.K., Burnett, A.K., Chopra, R., Wiernik, P.H., Foroni, L., Paietta, E., Litzow, M.R., Marks, D.I., Durrant, J., McMillan, A., Franklin, I.M., Luger, S., Ciobanu, N. & Rowe, J.M. (2008) In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved form a matched allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood, 111, 18271833.
  • Gupta, V., Yi, Q.-L., Brandwein, J., Minden, M.D., Schuh, A.C., Wells, R.A., Tsang, R., Daly, A., Lipton, J.H. & Messner, H.A. (2004) The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission: a donor vs no donor comparison. Bone Marrow Transplantation, 33, 397404.
  • Huguet, F., Leguay, T., Raffoux, E., Thomas, X., Beldjord, K., Delabesse, E., Chevallier, P., Buzyn, A., Delannoy, A., Chalandon, Y., Vernant, J.P., Lafage-Pochitaloff, M., Chassevent, A., Lhéritier, V., Macintyre, E., Béné, M.C., Ifrah, N. & Dombret, H. (2009) Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. Journal of Clinical Oncology, 27, 911918.
  • Kantarjian, H.M., O’Brien, S., Smith, T.L., Cortes, J., Giles, F.J., Beran, M., Pierce, S., Huh, Y., Andreeff, M., Koller, C., Ha, C.S., Keating, M.J., Murphy, S. & Freireich, E.J. (2000) Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. Journal of Clinical Oncology, 18, 547561.
  • Lazarus, H.M., Richards, S.M., Chopra, R., Litzow, M.R., Burnett, A.K., Wiernik, P.H., Franklin, I.M., Tallman, M.S., Cook, L., Buck, G., Durrant, I.J., Rowe, J.M. & Goldstone, A.H. (2006) Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993. Blood, 108, 465472.
  • Mancini, M., Scappaticci, D., Cimino, G., Nanni, M., Derme, V., Elia, L., Tafuri, A., Vignetti, M., Vitale, A., Cuneo, A., Castoldi, G., Saglio, G., Pane, F., Mecucci, C., Camera, A., Specchia, G., Tedeschi, A., Di Raimondo, F., Fioritoni, G., Fabbiano, F., Marmont, F., Ferrara, F., Cascavill, N., Todeschini, G., Nobile, F., Grazia Kropp, M., Leoni, P., Tabilio, A., Luppi, M., Annino, L., Mandelli, F. & Foà, R. (2005) A comprehensive genetic classification of adult acute lymphoblastic leukemia: analysis of the GIMEMA 0496 protocol. Blood, 105, 34343441.
  • Moorman, A.V., Harrison, C.J., Buck, G.A.N., Richards, S.M., Secker-Walker, L.M., Martineau, M., Vance, G.H., Cherry, A.M., Higgins, R.R., Fielding, A.K., Foroni, L., Paietta, E., Tallman, M.S., Litzow, M.R., Wiernik, P.H., Rowe, J.M., Goldstone, A.H. & Dewald, G.W. (2007) Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood, 109, 31893197.
  • Ojala, A.E., Lanning, F.P., Paakko, E. & Lanning, B.M. (1997) Osteonecrosis in children treated for acute lymphoblastic leukemia: a magnetic resonance imaging study after treatment. Medical Pediatric Oncology, 29, 260265.
  • Pagano, L., Pulsoni, A., Mele, L. & Leone, G. (2000) Clinical and epidemiologic features of acute lymphoblastic leukemia following a previous malignancy. Leukemia and Lymphoma, 39, 465475.
  • Patel, B., Richards, S.M., Rowe, J., Goldstone, A.H. & Fielding, A.K. (2008) High incidence of avascular necrosis in adolescents with acute lymphoblastic leukemia: a UKALL XII analysis. Leukemia, 22, 308312.
  • Pui, C.-H. & Evans, W.E. (2006) Treatment of acute lymphoblastic leukemia. New England Journal of Medicine, 354, 166178.
  • Ribera, J.-M., Oriol, A., Sanz, M.-A., Tormo, M., Fernandez-Abellan, P., Del Potro, E., Abella, E., Bueno, J., Parody, R., Bastida, P., Grande, C., Heras, I., Bethencourt, C., Feliu, E. & Ortega, J.-J. (2008) Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Espanol de Tratamiento en Hemtologica pediatric-base Protocol ALL-096. Journal of Clinical Oncology, 26, 18431849.
  • Rowe, J.M., Buck, G., Burnett, A.K., Chopra, R., Wiernik, P.H., Richards, S.M., Lazarus, H.M., Franklin, I.M., Litzow, M.R., Ciobanu, N., Prentice, H.G., Durrant, J., Tallman, M.S. & Goldstone, A.H. (2005) Induction chemotherapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood, 106, 37603767.
  • Schrappe, M., Reiter, A., Ludwig, W.D., Harbott, J., Zimmermann, M., Hiddemann, W., Niemeyer, C., Henze, G., Feldges, A., Zintl, F., Kornhuber, B., Ritter, J., Welte, K., Gadner, H. & Riehm, H. (2000) Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL BFM90. Blood, 95, 33103322.
  • Silverman, L.B., Gelber, R.D., Dalton, V.K., Asselin, B.L., Barr, R.D., Clavell, L.A., Hurwitz, C.A., Moghrabi, A., Samson, Y., Schorin, M.A., Arkin, S., Declerck, L., Cohen, H.J. & Sallan, S.E. (2001) Improved outcome for children with acute lymphoblastic leukemia: results of Dana Farber Consortium Protocol 91-01. Blood, 97, 12111218.
  • Thomas, X., Boiron, J.-M., Huguet, F., Dombret, H., Bradstock, K., Vey, N., Kovacsovics, T., Delannoy, A., Fegueux, N., Fenaux, P., Stamatoullas, A., Vernant, J.-P., Tournilhac, O., Buzyn, A., Reman, O., Charrin, C., Boucheix, C., Gabert, J., Lhéritier, V. & Fiere, D. (2004) Outcome of treatment in adults with acute lymphoblastic leukemia: Analysis of the LALA-94 trial. Journal of Clinical Oncology, 22, 40754086.
  • Vaidya, S., Saika, S., Sirohi, B., Pai, S. & Advani, S. (1998) Avascular necrosis of bone – a complication of aggressive therapy for acute lymphoblastic leukemia. Acta Oncology, 37, 175177.
  • Vey, N., Thomas, X., Picard, C., Kovascovicz, T., Charin, C., Cayuela, J.M., Dombret, H., Dastugue, N., Huguet, F., Bastard, C., Stamatoulas, A., Giollant, M., Tournilhac, O., Macintyre, E., Buzyn, A., Bories, D., Kuentz, M., Dreyfus, F., Delannoy, A., Raynaud, S., Gratecos, N., Bordessoule, D., De.Botton, S., Preudhomme, C., Reman, O., Troussard, X., Pigneux, A., Bilhou, C., Vernant, J.P., Boucheix, C. & Gabert, J. (2006) Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study. Leukemia, 20, 21552161.